The Nutshell

» clinical trials and cell & molecular biology

Daily News Roundup

Most Recent

image: CRISPR Therapy to Enter Trials

CRISPR Therapy to Enter Trials

By | July 25, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

Juno Therapeutics asks the US Food and Drug Administration for permission to restart the CAR-T experiments without chemotherapy.

0 Comments

image: Vaccines Protect Mice Against Zika Infection

Vaccines Protect Mice Against Zika Infection

By | June 29, 2016

Two different vaccines confer complete immunity for two months, researchers report.

0 Comments

image: NYU Halts Studies, Suspends Investigator

NYU Halts Studies, Suspends Investigator

By | June 28, 2016

Experiments conducted at the New York University School of Medicine violated several research standards, according to US Food and Drug Administration investigators.

2 Comments

image: Zika Vaccine Ready for Human Trials

Zika Vaccine Ready for Human Trials

By | June 21, 2016

The US Food and Drug Administration has approved a clinical trial to test the vaccine on healthy adults.

0 Comments

image: Journal to Publish Clinical Trial Protocols

Journal to Publish Clinical Trial Protocols

By | May 18, 2016

Following an independent group’s finding of misreported outcomes, the Annals of Internal Medicine now requires that authors include clinical trial protocols when submitting their results.

0 Comments

image: Embryo Watch

Embryo Watch

By | May 5, 2016

A new culture system allows researchers to track the development of human embryos in vitro for nearly two weeks. 

1 Comment

image: Observing the Nuclear Pore

Observing the Nuclear Pore

By | May 2, 2016

Scientists visualize nuclear pore complexes for the first time, using high-speed atomic force microscopy.

1 Comment

image: Another Fatal-Disease Drug in Limbo

Another Fatal-Disease Drug in Limbo

By | April 26, 2016

A federal advisory panel votes against Sarepta Therapeutics’s treatment for Duchenne muscular dystrophy.

0 Comments

image: Two NIH Labs Cease Reagent Production

Two NIH Labs Cease Reagent Production

By | April 20, 2016

Contamination concerns at cell therapy and radioactive tracer facilities spur production shutdowns.

0 Comments

Popular Now

  1. Exercise Boosts Telomere Transcription
  2. Neurons Compete to Form Memories
  3. Classic Example of Symbiosis Revised
  4. The Genetic Components of Rare Diseases
RayBiotech